These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 29533936

  • 1. N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5.
    Liang Y, Xu W, Liu S, Chi J, Zhang J, Sui A, Wang L, Liang Z, Li D, Chen Y, Niu H.
    Cell Physiol Biochem; 2018; 45(5):2054-2070. PubMed ID: 29533936
    [Abstract] [Full Text] [Related]

  • 2. Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
    Kim YH, Shin EA, Jung JH, Park JE, Koo J, Koo JI, Shim BS, Kim SH.
    Eur J Pharmacol; 2019 Mar 15; 847():91-96. PubMed ID: 30689998
    [Abstract] [Full Text] [Related]

  • 3. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424
    [Abstract] [Full Text] [Related]

  • 4. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
    Zhuang H, Jiang W, Zhang X, Qiu F, Gan Z, Cheng W, Zhang J, Guan S, Tang B, Huang Q, Wu X, Huang X, Jiang W, Hu Q, Lu M, Hua ZC.
    J Mol Med (Berl); 2013 Feb 15; 91(2):219-35. PubMed ID: 22948392
    [Abstract] [Full Text] [Related]

  • 5. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells.
    Xie ZH, Quan MF, Liu F, Cao JG, Zhang JS.
    BMC Cancer; 2011 Jul 29; 11():322. PubMed ID: 21801359
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells.
    Jin CY, Park C, Hwang HJ, Kim GY, Choi BT, Kim WJ, Choi YH.
    Mol Nutr Food Res; 2011 Feb 29; 55(2):300-9. PubMed ID: 20669244
    [Abstract] [Full Text] [Related]

  • 8. Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.
    Tian S, Liu DH, Wang D, Ren F, Xia P.
    Cell Physiol Biochem; 2018 Feb 29; 51(1):217-227. PubMed ID: 30448845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
    Yang J, Chen SZ.
    Yao Xue Xue Bao; 2010 Oct 29; 45(10):1247-53. PubMed ID: 21348302
    [Abstract] [Full Text] [Related]

  • 11. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 29; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 12. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY, Hong M, Heo SH, Park S, Kwon TK, Sung YH, Oh Y, Lee S, Yi GS, Kim I.
    Mol Carcinog; 2018 Nov 01; 57(11):1492-1506. PubMed ID: 29964331
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer.
    Yang J, Yang C, Zhang S, Mei Z, Shi M, Sun S, Shi L, Wang Z, Wang Y, Li Z, Xie C.
    Cancer Biol Ther; 2015 Nov 01; 16(8):1194-204. PubMed ID: 26054751
    [Abstract] [Full Text] [Related]

  • 17. Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells.
    Ouyang W, Yang C, Liu Y, Xiong J, Zhang J, Zhong Y, Zhang G, Zhou F, Zhou Y, Xie C.
    Int J Oncol; 2011 Dec 01; 39(6):1577-86. PubMed ID: 21769428
    [Abstract] [Full Text] [Related]

  • 18. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S, Tripathi N, Preet R, Siddharth S, Nayak A, Bharatam PV, Kundu CN.
    Oncotarget; 2017 Jan 03; 8(1):248-267. PubMed ID: 27542249
    [Abstract] [Full Text] [Related]

  • 19. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
    Lian B, Yang D, Liu Y, Shi G, Li J, Yan X, Jin K, Liu X, Zhao J, Shang W, Zhang R.
    Cell Physiol Biochem; 2018 Jan 03; 49(6):2151-2162. PubMed ID: 30257253
    [Abstract] [Full Text] [Related]

  • 20. Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing.
    Wilson TR, Redmond KM, McLaughlin KM, Crawford N, Gately K, O'Byrne K, Le-Clorrenec C, Holohan C, Fennell DA, Johnston PG, Longley DB.
    Cell Death Differ; 2009 Oct 03; 16(10):1352-61. PubMed ID: 19543235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.